Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Sales | 983 | 431 | 574 | 809 | 0 |
| Cost of Goods | 124 | 390 | 819 | 835 | N/A |
| Gross Profit | 859 | 41 | -245 | -26 | N/A |
| Operating Expenses | 94,808 | 79,572 | 29,786 | 34,521 | 9,382 |
| Operating Income | -93,825 | -79,141 | -29,212 | -33,712 | -9,382 |
| Other Income | 4,555 | 6,393 | 2,317 | 770 | 247 |
| Pre-tax Income | -89,270 | -72,748 | -26,895 | -32,942 | -9,135 |
| Income Tax | 36 | N/A | N/A | 1 | -27 |
| Net Income Continuous | -89,306 | -72,748 | -26,895 | -32,943 | -9,108 |
| Net Income Discontinuous | -756 | -1,016 | N/A | N/A | N/A |
| Net Income | $-90,062 | $-73,764 | $-26,895 | $-32,943 | $-9,108 |
| EPS Basic Total Ops | -2.07 | -1.76 | -0.78 | -1.10 | -0.43 |
| EPS Basic Continuous Ops | -2.05 | -1.74 | -0.78 | -1.10 | -0.43 |
| EPS Basic Discontinuous Ops | -0.02 | -0.02 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.07 | -1.76 | -0.78 | -1.10 | -0.43 |
| EPS Diluted Continuous Ops | -2.05 | -1.74 | -0.78 | -1.10 | -0.43 |
| EPS Diluted Discontinuous Ops | -0.02 | -0.02 | N/A | N/A | N/A |
| EBITDA(a) | $-93,695 | $-78,965 | $-29,022 | $-33,557 | $-8,442 |